Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge

Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge

FUNDING. National Institute of Allergy and Infectious Diseases and Bill & Melinda Gates Foundation.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2021-08, Vol.131 (16)
Hauptverfasser: Astronomo, Rena D, Lemos, Maria P, Narpala, Sandeep R, Czartoski, Julie, Fleming, Lamar Ballweber, Seaton, Kelly E, Prabhakaran, Madhu, Huang, Yunda, Lu, Yiwen, Westerberg, Katharine, Zhang, Lily, Gross, Mary K, Hural, John, Tieu, Hong- Van, Baden, Lindsey R, Hammer, Scott, Frank, Ian, Ochsenbauer, Christina, Grunenberg, Nicole, Ledgerwood, Julie E, Mayer, Kenneth, Tomaras, Georgia, McDermott, Adrian B, McElrath, M. Juliana
Format: Artikel
Sprache:eng
Schlagworte:
Anti-HIV agents
Antiviral agents
Clinical Medicine
Dosage and administration
Drug therapy
Health aspects
HIV infection
Monoclonal antibodies
Physiological aspects
Rectum
Testing
Vagina
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FUNDING. National Institute of Allergy and Infectious Diseases and Bill & Melinda Gates Foundation.
ISSN:1558-8238
0021-9738
1558-8238
DOI:10.1172/JCI146975